France’s Cellectis wins US patents for gene editing technology – Business Insider
Business Wire (press release) |
France's Cellectis wins US patents for gene editing technology
Business Insider "These inventions are based on the early work initiated by inventors at Cellectis when the CRISPR technology first came to light," the company said. CRISPR, an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats, forms the basis … Two Issued US Patents Granted to Cellectis for CRISPR Use in T-Cells |
